Braig, David
University of Freiburg · University Medical Center Freiburg
5 papers on CoChatORCID 0000-0002-1267-0840
Most cited papers
- Verified
Promiscuous targeting of polytopic membrane proteins to SecYEG or YidC by the Escherichia coli signal recognition particle
Welte, T., Kudva, R., Kuhn, P., Sturm, L., Braig, D., Müller, M., Warscheid, B., Drepper, F., & Koch, H.-G. (2012) · Molecular Biology of the Cell
Bacterial Genetics and BiotechnologyRNA and protein synthesis mechanisms
Cited by 87
- Verified
Genotyping of circulating cell-free DNA enables noninvasive tumor detection in myxoid liposarcomas
Braig, D., Becherer, C., Bickert, C., Braig, M., Claus, R., Eisenhardt, A. E., Heinz, J., Scholber, J., Herget, G. W., Bronsert, P., et al. (2019) · International Journal of Cancer
Sarcoma Diagnosis and TreatmentCancer Genomics and Diagnostics
Cited by 42
- Verified
Genotyping of Circulating Free DNA Enables Monitoring of Tumor Dynamics in Synovial Sarcomas
Eisenhardt, A. E., Brugger, Z., Lausch, U., Kiefer, J., Zeller, J., Runkel, A., Schmid, A., Bronsert, P., Wehrle, J., Leithner, A., et al. (2022) · Cancers
Cancer Genomics and DiagnosticsSarcoma Diagnosis and Treatment
Cited by 18
- Verified
Targeted next-generation sequencing of circulating free DNA enables non-invasive tumor detection in myxoid liposarcomas
Eisenhardt, A. E., Schmid, A., Esser, J., Brugger, Z., Lausch, U., Kiefer, J., Braig, M., Runkel, A., Wehrle, J., Claus, R., et al. (2022) · Molecular Cancer
Cancer Genomics and DiagnosticsSarcoma Diagnosis and Treatment
Cited by 10
- Verified
Improved Quantification of Circulating Tumor DNA in Translocation‐Associated Myxoid Liposarcoma by Simultaneous Detection of Breakpoints and Single Nucleotide Variants
Schmid, A., Lausch, U., Runkel, A., Kiefer, J., Pauli, T., Boerries, M., Bogner, B., Eisenhardt, S. U., & Braig, D. (2025) · Cancer Medicine
Cancer Genomics and DiagnosticsSarcoma Diagnosis and Treatment
Cited by 4
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free